You may also like
Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19
The present findings suggested that about half of adult patients with severe COVID-19–related ARDS can be managed successfully with ECMO with sustained results at six months. Decreased arterial pH before ECMO was associated significantly with early mortality. Therefore, the authors hypothesized that initiation of ECMO therapy before severe metabolic derangements subset may improve survival rates significantly in these patients. These results should be viewed in the light of a strict patient selection policy and may not be replicated in patients with advanced age or multiple comorbidities.
1 min read
Left Atrial Inflow and Outflow Obstruction as a Complication of Retrograde Approach for Chronic Total Occlusion: Report of a Case and Literature Review of Left Atrial Hematoma After Percutaneous Coronary Intervention
Retrograde recanalization of a chronic coronary total occlusion (CTO) has become an increasingly utilized method to increase success from percutaneous coronary intervention (PCI).
1 min read
Monitoring Activated Clotting Time for Combined Heparin and Aprotinin Application: In Vivo Evaluation of a New Aprotinin-Insensitive Test Using Sonoclot
The aim of our study was to evaluate SaiACT in patients undergoing CPB in presence of heparin and aprotinin.
1 min read